NetScientific plc
(“NetScientific” or the “Company” or the “Group”)
Result of Annual General Meeting
London, UK – June 21st 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic biomedical and healthcare technology group, announces that all resolutions proposed at today’s Annual General Meeting, were duly passed.
# # #
For more information, please contact:
|
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO |
Tel: +44 (0)20 3514 1800 |
|
Consilium Strategic Communications Mary-Jane Elliott Jessica Hodgson / Chris Welsh / Laura Thornton |
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
|
Stifel Nicolaus Europe Limited (NOMAD and Broker) Jonathan Senior / David Arch / Ben Maddison |
Tel: +44 (0) 20 7710 7600 |
About NetScientific
NetScientific is an IP commercialisation group focused on healthcare with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
